On the heels of human clinical studies that indicate tocotrienols found in palm fruit oil appear to reduce the severity of end-stage liver disease, new research has come out indicating that nearly 10 percent of U.S. teens have nonalcoholic fatty liver disease (NFLD). NFLD is largely silent accumulation of fat in liver cells that puts teens at risk for developing later cardiovascular disease and additional liver problems. This research, reported by ABC News, suggests that the culprit may be teenage obesity.
In the ABC News report, the researchers are quoted as saying, “ … the prevalence of fatty liver among U.S. teens has more than doubled in the past two decades, from 3.6 percent to 9.9 percent, outpacing the rise in teenage obesity during that time and suggesting obesity is only a partial explanation for a rise.”
Research at Ohio State University, funded by the National Institutes of Health, has found that tocotrienols may either slow the progression of liver disease or enable a patient to cut back on therapies, which are often not well tolerated. A second human clinical trial on NFLD, conducted by researchers in Malaysia, will be published soon.